VYCO
VYCOR MEDICAL INCPrice
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
- R Mar 31 Vycor Medical reported annual financial results for 2025, showing 17…
- R Aug 14 Vycor Medical reported Q2 2026 revenue of $418,264, a 16% decline Yo…
- X Aug 31 Short interest jumps 186.2% to 19.1K
- X Sep 15 Short interest falls 36.7% to 12.1K
Signal stack
Where each data set points today.
- TrendDOWNTREND
32% below its 50-day average. New closing low $0.0340 on Oct 21.
Earnings setup
Estimates| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | — | — | — | $0.00 |
| Next Q | — | — | — | $0.00 |
| Current FY | — | — | — | $0.00 |
| Next FY | — | — | — | $0.00 |
Short side
FINRA· Oct 15, 2026SecBot reports
3 filings · 1 bullish · 1 bearish · 1 neutral- BEARISH 8-KAug 14, 2026
Vycor Medical reported Q2 2026 revenue of $418,264, a 16% decline YoY, driven by a 17% drop in the…
The sharp revenue decline in the core VBAS business, particularly from international markets, signals a material operational setback. Monitor the next quarter for a recovery in international orders…
- NEUTRAL 8-KMay 15, 2026
Vycor Medical reported Q1 2026 revenue of $458,540 (+5% YoY) and swung to a GAAP operating profit…
The company is showing operational improvement but remains sub-scale and unprofitable for common shareholders after preferred dividends. Monitor for sustained VBAS revenue acceleration and any…
- BULLISH 8-KMar 31, 2026
Vycor Medical reported annual financial results for 2025, showing 17% revenue growth to $1.86…
Monitor next quarter's earnings for continued international growth trends and margin stabilization, as the current margin compression from international expansion and new production costs could…
All VYCO filing & press-release reports (3)
- 8-K reportAug 14, 2026
- 8-K reportMay 15, 2026
- 8-K reportMar 31, 2026